Cargando…
Enzyme replacement in the CSF to treat metachromatic leukodystrophy in mouse model using single intracerebroventricular injection of self-complementary AAV1 vector
Metachromatic leukodystrophy (MLD) is a lysosomal storage disease caused by a functional deficiency in human arylsulfatase A (hASA). We recently reported that ependymal cells and the choroid plexus are selectively transduced by intracerebroventricular (ICV) injection of adeno-associated virus seroty...
Autores principales: | Hironaka, Kohei, Yamazaki, Yoshiyuki, Hirai, Yukihiko, Yamamoto, Motoko, Miyake, Noriko, Miyake, Koichi, Okada, Takashi, Morita, Akio, Shimada, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539541/ https://www.ncbi.nlm.nih.gov/pubmed/26283284 http://dx.doi.org/10.1038/srep13104 |
Ejemplares similares
-
Treatment of adult metachromatic leukodystrophy model mice using intrathecal administration of type 9 AAV vector encoding arylsulfatase A
por: Miyake, Noriko, et al.
Publicado: (2021) -
Targeted gene transfer into ependymal cells through intraventricular injection of AAV1 vector and long-term enzyme replacement via the CSF
por: Yamazaki, Yoshiyuki, et al.
Publicado: (2014) -
Intrathecal baclofen in metachromatic leukodystrophy
por: van der Veldt, Nikki, et al.
Publicado: (2018) -
Developing therapeutic approaches for metachromatic leukodystrophy
por: Patil, Shilpa A, et al.
Publicado: (2013) -
Diffusion tensor imaging in metachromatic leukodystrophy
por: van Rappard, Diane F., et al.
Publicado: (2018)